About Curia
Curia is a Healthcare company based in Grafton (United States) founded in 1998, and was acquired by Curia in March 2014. Drug research and development services for rare diseases are provided. It operates on a Professional Services and Managed Services model. Curia has completed 1 acquisition, including AF Hauser. Its chief executive, as recorded, is John Ratliff. Curia offers products and services including Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product. Its focus areas include Pharmaceuticals and Contract Development and Manufacturing. Its legal entity is Curia Global, Inc. Its competitors include Crown Bioscience, Alloy Therapeutics and NIH; 2 of its 3 listed competitors have raised funding.
Company details
Curia is involved in providing comprehensive contract development and manufacturing services for the pharmaceutical and biopharmaceutical industries. Services are offered across small molecules, generic APIs, biologics, and sterile drug products. The company supports clients through drug discovery, development, and manufacturing phases with a global network of facilities in North America, Europe, and India. Advanced technologies and scientific expertise are utilized to ensure flexibility and scalability in delivering solutions. Curia is dedicated to accelerating the delivery of therapies to patients while maintaining high standards of quality and excellence.
- Headquarters Grafton, United States
- Stage Acquired
- SectorsHealthcare
- Website cedarburgpharma.com
- Social LinkedIn X Facebook
- Acquired by Curia (Mar 2014)
- Legal Name Curia Global, Inc.
Products & Services of Curia
Curia offers a comprehensive portfolio of products and services, including Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product.
Services for small molecule drug discovery are provided.
Generic API manufacturing and catalog services are offered.
Biologics discovery and manufacturing solutions are delivered.
Sterile drug product development services are provided.
Investors in Curia
Curia has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Curia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug research, development, testing, and consulting services are provided. | 1991 | curiaglobal.com | Albany, United States |
Investor details for Curia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Curia
1 people are tracked at Curia (1 in leadership).
| Name | Role | Group |
|---|---|---|
John Ratliff | CEO | Leadership |
Complete people profiles for Curia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Curia
Curia has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AF Hauser.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Distributor of generic pharmaceutical drugs | hauserpharmaceutical.com | Valparaiso, United States | 1983 | May 2009 | •••• |
Complete acquisition details for Curia
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Competitors of Curia
Curia has 3 listed competitors in our database, 2 of them funded. They include Crown Bioscience, Alloy Therapeutics and NIH.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| crownbio.com | 2006 | Santa Clara, United States | $85.87M | 18 | Cancer and CVMD drugs are developed using PDX models. | |
| alloytx.com | 2017 | Lexington, United States | $157M | Drug discovery services are provided for therapeutic development. | ||
| nih.gov | 1887 | United States | Drug discovery services are provided to the biopharma sector. |
Detailed competitors of Curia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Curia
Websites that share an audience with Curia (cedarburgpharma.com).
Websites whose visitors overlap most with Curia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| porwal.net | 100% | 1.1K | #14,642,220 | View details | |
hengshunchem.com | hengshunchem.com | 100% | – | ||
| cfb.de | 100% | View details | |||
| enzal.com | 100% | View details | |||
| u-g.com | 100% | 3.2K | #7,045,168 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Curia
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Curia (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Curia
Complete news archive for Curia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curia
Curia was founded in 1998.
Curia is headquartered in Grafton, United States.
John Ratliff is the CEO of Curia, as recorded in our data.
Curia is involved in providing comprehensive contract development and manufacturing services for the pharmaceutical and biopharmaceutical industries. Services are offered across small molecules, generic APIs, biologics, and sterile drug products. The company supports clients through drug discovery, development, and manufacturing phases with a global network of facilities in North America, Europe, and India. Advanced technologies and scientific expertise are utilized to ensure flexibility and scalability in delivering solutions. Curia is dedicated to accelerating the delivery of therapies to patients while maintaining high standards of quality and excellence.
Curia's top competitors include Crown Bioscience, NIH and Alloy Therapeutics.
Curia offers Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product.
Curia has made 1 acquisition, including AF Hauser.
Curia has 1 investor. Key investors include Curia.
Curia operates through Curia Global, Inc..
Yes. Curia was acquired by Curia in March 2014.